Abstracts Archive - Page 1200 of 2607 - ACR Meeting Abstracts

Abstract Number: 203 • 2018 ACR/ARHP Annual Meeting
Meat Consumption and Risk of Rheumatoid Arthritis in Women: A Population-Based Cohort Study
Daniela Di Giuseppe¹, Lotta Ljung² and Bjorn Sundstrom², ¹Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, ²Department of Public Health and Clinical Medicine/Rheumatology,, Umeå University, Umeå, Sweden
Background/Purpose: Mixed results have been reported for the association between meat consumption and the risk of developing rheumatoid arthritis (RA). The aim of this study…
Abstract Number: 204 • 2018 ACR/ARHP Annual Meeting
Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis
Vanessa L. Kronzer¹, Cynthia S. Crowson², Jeffrey A. Sparks³, Robert Vassallo⁴ and John M. Davis III⁵, ¹Internal Medicine, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁵Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Several studies show an association between asthma and RA. However, none have controlled for allergic disease, urban environment, or passive smoke exposure. We aimed…
Abstract Number: 205 • 2018 ACR/ARHP Annual Meeting
Circulating Plasma Metabolites and Risk of Rheumatoid Arthritis in the Nurses Health Study
Su Chu^1,2, Jeffrey A. Sparks^1,3, Jing Cui⁴, Sara K. Tedeschi^3,5, Cameron Speyer³, Cianna Leatherwood^1,3, Medha Barbhaiya⁶, Clary Clish⁷, Kevin D. Deane⁸, Jessica Su^1,2, Karen Costenbader^1,3 and Elizabeth Karlson^1,9, ¹Medicine, Harvard Medical School, Boston, MA, ²Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA, ⁵American College of Rheumatology, Atlanta, GA, ⁶Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, ⁷Broad Institute of MIT and Harvard, Boston, MA, ⁸Division of Rheumatology, University of Colorado Denver, Aurora, CO, ⁹Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Rheumatoid arthritis (RA) develops insidiously, often over many years. Given that diet and obesity have been associated with increased RA risk, we investigated whether…
Abstract Number: 206 • 2018 ACR/ARHP Annual Meeting
Impact of International Classification of Diseases 10th Revision Codes and Updated Medical Information on an Existing Rheumatoid Arthritis Phenotype Algorithm Using Electronic Medical Data
Sicong Huang¹, Jie Huang¹, Tianrun Cai², Kumar P. Dahal³, Andrew Cagan⁴, Jacklyn Stratton³, Tianxi Cai⁵ and Katherine P. Liao³, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, ³Brigham and Women's Hospital, Boston, MA, ⁴Research Computing, Partners HealthCare, Charlestown, MA, ⁵Harvard T.H. Chan School of Public Health, Boston, MA
Background/Purpose: Electronic medical records (EMRs) are increasingly being utilized for clinical research, where the phenotypes of interest are typically defined by algorithms. Almost a decade…
Abstract Number: 207 • 2018 ACR/ARHP Annual Meeting
Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipids and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis
Katherine P. Liao¹, Jie Huang², Gabrielle Cremone³, Ethan Lam³, Nicole Yang¹, Martin Playford⁴, Christine K Iannaccone¹, Jonathan Coblyn⁵, Elena Massarotti¹, Michael E Weinblatt⁵, Nancy A. Shadick¹, Nehal Mehta⁴ and Jorge Plutzky¹, ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁴NHLBI, Bethesda, MD, ⁵Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Inflammation is an independent risk factor for cardiovascular (CV) risk in rheumatoid arthritis (RA). Paradoxically, potentially cardioprotective decreases in inflammation is associated with increased…
Abstract Number: 208 • 2018 ACR/ARHP Annual Meeting
Antibodies to Citrullinated Protein Antigens Are Associated with Risk of Cardiovascular Disease in Community-Dwelling Women: The Multi-Ethnic Study of Atherosclerosis
Jan M. Hughes-Austin¹, Ronit Katz², Gary S. Firestein³, Michael H. Criqui⁴, William H. Robinson⁵ and Joachim H. Ix⁶, ¹Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, ²University of Washington, Seattle, WA, ³Medicine, University of California San Diego, La Jolla, CA, ⁴Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, ⁵Stanford, Stanford, CA, ⁶Nephrology-Hypertension, University of California, San Diego, La Jolla, CA
Antibodies to Citrullinated Protein Antigens are Associated with Risk of Cardiovascular Disease in Community Dwelling Women: The Multi-Ethnic Study of Atherosclerosis Background/Purpose: Risk for cardiovascular…
Abstract Number: 209 • 2018 ACR/ARHP Annual Meeting
Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative
Kangping Cui^1,2, Mohammad Movahedi³, Claire Bombardier⁴ and Bindee Kuriya⁵, ¹Internal Medicine, University of Western Ontario, London, ON, Canada, ²Toronto General Hospital Research Institute, Toronto, ON, Canada, ³JSS Medical Research, St-Laurent, QC, Canada, ⁴Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, ⁵Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research InitiativeBackground/Purpose: Cardiovascular disease (CVD) is…
Abstract Number: 210 • 2018 ACR/ARHP Annual Meeting
Changes in Alcohol Use in Patients with Rheumatoid Arthritis: Associations with Disease Activity, Health Status, and Mortality
Joshua Baker¹, Harlan Sayles², Bryant R. England³, Ted R. Mikuls⁴ and Kaleb Michaud⁵, ¹Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, ²University of Nebraska Medical Center, Omaha, NE, ³Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, ⁴Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, ⁵Rheumatology, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Prior studies observed better disease control, quality of life, and physical function among patients with rheumatoid arthritis (RA) who drink alcohol. These studies may…
Abstract Number: 211 • 2018 ACR/ARHP Annual Meeting
Excess in Prevalence of Functional Disability in Patients with Rheumatoid Arthritis: Does Serologic Status Matter?
Elena Myasoedova¹, John M. Davis III¹, Sara J. Achenbach², Eric L. Matteson¹ and Cynthia S. Crowson², ¹Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Despite the advances in treatment of rheumatoid arthritis (RA) over the recent decades, many patients with RA do not achieve remission or full physical…
Abstract Number: 212 • 2018 ACR/ARHP Annual Meeting
Mortality and Causes of Death in Patients with Inflammatory Arthritis in Hong Kong over 20 Years
Tommy Tsang Cheung, Simon Man Fung Tsoi, Bernard Man Yung Cheung and Chak Sing Lau, Medicine, The University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: Patients with inflammatory arthritis have a higher mortality than the general population due to increased risks of cardiovascular diseases, infection and cancer. As the…
Abstract Number: 213 • 2018 ACR/ARHP Annual Meeting
Excessive Risk of Major Cardiovascular Events in Sero-Positive Rheumatoid Arthritis and in Patients with Active Disease
Annette de Thurah^1,2, Ina Trolle Andersen³, Andreas Bugge Tingaard⁴, Josephine Therkildsen⁵, Anders Hammerich Riis³, Morten Böttcher⁵ and Ellen-Margrethe Hauge^6,7, ¹Department of Rheumatology, Aarhus University Hospital, Århus C, Denmark, ²Department of Clinical Medicine, Aarhus University, Aarhus, DK, Aarhus N, Denmark, ³Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, ⁴Department of Cardiology, Regional Hospital of Herning, Herning, Denmark, ⁵Cardiology, Regional Hospital of Herning, Herning, Denmark, ⁶Department of Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ⁷Department of Clinical Medicine, Aarhus University, Aarhus C, Denmark
Background/Purpose: Rheumatoid arthritis (RA) is a known risk factor for the development of cardiovascular disease (CVD). However, the influence of RA on the prognosis after…
Abstract Number: 214 • 2018 ACR/ARHP Annual Meeting
Exploring the Relation between Air Pollution and Disease Activity in Patients with Rheumatoid Arthritis
Tommaso Schioppo¹, Valentina Bollati^2,3, Chiara Favero^2,3, Nicola Ughi¹, Isabella Scotti¹, Valeria Merlino¹, Orazio De Lucia¹, Antonella Murgo¹ and Francesca Ingegnoli^1,3, ¹Division of Clinical Rheumatology, G. Pini Hospital, Milan, Italy, ²EPIGET Lab, Milan, Italy, ³Dept. of Clinical Sciences & Community Health, Università degli Studi di Milano, Milan, Italy
Background/Purpose: Disease remission is considered an achievable target in a significant proportion of patients with rheumatoid arthritis (RA). Nevertheless, diseases flares, that significantly contributes to…
Abstract Number: 215 • 2018 ACR/ARHP Annual Meeting
A Decade Earlier- Onset of Symptoms of RA in the Indian (Asian) Cohort Compared to Dutch Cohort: Based on Meteor, a Global Database
Arvind Chopra¹, Manjit Saluja², Sytske Anne Bergstra³, Toktam Kainifard⁴, Anuradha Venugopalan⁵ and Tom W.J. Huizinga³, ¹Center for Rheumatic Diseases, Pune, India, ²Rheumatology, Research Co-ordinator, Pune, India, ³Department of Rheumatology, LUMC, Leiden, Netherlands, ⁴Rheumatology, Consultant research and Dietitian, Tehran, Iran (Islamic Republic of), ⁵Rheumatology, R & D, Lab, Center for Rheumatic Diseases, Pune, India
Background/Purpose: Reported symptom onset and diagnosis debut in rheumatoid arthritis (RA) patients may be influenced by environmental factors, genetics and gene-environmental interactions, but also by…
Abstract Number: 216 • 2018 ACR/ARHP Annual Meeting
Inflectra and Remicade Use and Cost in Canada Under Provincial Drug Plans in 2016
Cristiano S. Moura¹, Denis Choquette², Gilles Boire³, Vivian P. Bykerk⁴, Carter Thorne⁵, Walter P. Maksymowych⁶, Peter Lakatos⁷, Talat Bessissow⁸, Larry Svenson⁹, Laura Targownik¹⁰, Waqqas Afif⁸ and Sasha Bernatsky¹¹, ¹The Centre for Outcomes Research and Evaluation (CORE), McGill University Health Centre, Montreal, QC, Canada, ²Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, ³Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, ⁴Hospital for Special Surgery, New York, NY, ⁵University of Toronto, Newmarket, ON, Canada, ⁶Department of Medicine, CaRE Arthritis and University of Alberta, Edmonton, Canada, Edmonton, AB, Canada, ⁷Medicine, Gastroenterology, McGill University, Montreal, QC, Canada, ⁸Gastroenterology, McGill University, Montreal, QC, Canada, ⁹Division of Preventive Medicine, University of Alberta, Edmonton, AB, Canada, ¹⁰Gastroenterology, University of Manitoba, Winnipeg, MB, Canada, ¹¹Divisions of Rheumatology and Clinical Epidemiology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Inflectra (infliximab) was the first biosimilar for inflammatory bowel disease and/or arthritis, approved by Health Canada on the belief that it is as safe…
Abstract Number: 217 • 2018 ACR/ARHP Annual Meeting
Association between Comorbidities and Socioeconomic Status Among Patients with Rheumatoid Arthritis in Korea
Seunghwan Shin¹, Anna Shin¹, Ji Hyoun Kim², You-Jung Ha¹, Yun Jong Lee¹, Yeong Wook Song³ and Eun Ha Kang¹, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of (South), ²Department of Internal Medicine, Chungbuk National University Hospital, Chungcheongbuk-do, Korea, Republic of (South), ³Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Increased prevalence of comorbidities in patients with rheumatoid arthritis (RA) compared to general population has been noted in several previous study. This study aims…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].